Difference between revisions of "Part:BBa K2908670"
Line 4: | Line 4: | ||
The CSU_CHINA iGEM team 2019 designed a fusion protein consisting of yCD and miR101-BS for sequence-specific expression of yCD .Therefore, we used our miR101-BD(BBa_K2908668) to bind different concentrations of miR101 so that regulate the transactivation domain of yCD(BBa_K2908667).CD converts the prodrug 5-FC (used to treat infections by fungi such as Candida albicans and Cryptococcus neoformans) into the active agent 5-fluorouracil (5-FU). While 5-FC is nontoxic to human cells because of the lack of CD, 5-FU is used to treat cancers like colon, pancreatic, and breast cancer. The cytotoxic effects of 5-FU occur following its conversion to 5-fluoro-2'-deoxyuridine-5'-monophosphate (5-FdUMP). 5-FdUMP is an irreversible inhibitor of thymidylate synthase and thus inhibits DNA synthesis by deoxythymidine triphosphate (dTTP) deprivation and causes DNA strand breakage, leading to cell death. | The CSU_CHINA iGEM team 2019 designed a fusion protein consisting of yCD and miR101-BS for sequence-specific expression of yCD .Therefore, we used our miR101-BD(BBa_K2908668) to bind different concentrations of miR101 so that regulate the transactivation domain of yCD(BBa_K2908667).CD converts the prodrug 5-FC (used to treat infections by fungi such as Candida albicans and Cryptococcus neoformans) into the active agent 5-fluorouracil (5-FU). While 5-FC is nontoxic to human cells because of the lack of CD, 5-FU is used to treat cancers like colon, pancreatic, and breast cancer. The cytotoxic effects of 5-FU occur following its conversion to 5-fluoro-2'-deoxyuridine-5'-monophosphate (5-FdUMP). 5-FdUMP is an irreversible inhibitor of thymidylate synthase and thus inhibits DNA synthesis by deoxythymidine triphosphate (dTTP) deprivation and causes DNA strand breakage, leading to cell death. | ||
− | + | https://static.igem.org/mediawiki/parts/1/18/T--CSU_CHINA--module3.png | |
<!-- Add more about the biology of this part here | <!-- Add more about the biology of this part here | ||
===Usage and Biology=== | ===Usage and Biology=== |
Revision as of 21:27, 17 October 2019
pLN431-G8p-yCD-miR101BS
The CSU_CHINA iGEM team 2019 designed a fusion protein consisting of yCD and miR101-BS for sequence-specific expression of yCD .Therefore, we used our miR101-BD(BBa_K2908668) to bind different concentrations of miR101 so that regulate the transactivation domain of yCD(BBa_K2908667).CD converts the prodrug 5-FC (used to treat infections by fungi such as Candida albicans and Cryptococcus neoformans) into the active agent 5-fluorouracil (5-FU). While 5-FC is nontoxic to human cells because of the lack of CD, 5-FU is used to treat cancers like colon, pancreatic, and breast cancer. The cytotoxic effects of 5-FU occur following its conversion to 5-fluoro-2'-deoxyuridine-5'-monophosphate (5-FdUMP). 5-FdUMP is an irreversible inhibitor of thymidylate synthase and thus inhibits DNA synthesis by deoxythymidine triphosphate (dTTP) deprivation and causes DNA strand breakage, leading to cell death. Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12INCOMPATIBLE WITH RFC[12]Illegal NheI site found at 197
Illegal NheI site found at 1143 - 21INCOMPATIBLE WITH RFC[21]Illegal BglII site found at 244
Illegal XhoI site found at 60
Illegal XhoI site found at 174 - 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000INCOMPATIBLE WITH RFC[1000]Illegal BsaI.rc site found at 755
Illegal BsaI.rc site found at 792